<table border="1"><tr><th>IUPAC nomenclature</th><td><ul><li>2-Methyl-4-(4-methyl-1-piperazinyl)-10 | H | -thieno[2,3- | b | ][1,5]benzodiazepine</li></ul></td></tr><tr><th>Identity information.</th><td><ul><li>CAS Registry | 132539-06-1 | ATC Code | N05 | AH03 | PubChem | 4585 | Drumbank | DB00334 | ChemSpider | 10442212.</li></ul></td></tr><tr><th>Chemical properties</th><td><ul><li>chemistry | C | 17 | H | 20 | N | 4 | S | molecular weight | 312.439 | SMILES | eMolecules | &amp; | PubChem</li></ul></td></tr><tr><th>physical properties</th><td><ul><li>melting point | 195 °C (383 °F) | water solubility | Practically insoluble in water mg/mL (20 °C)</li></ul></td></tr><tr><th>Pharmaceutical Information</th><td><ul><li>Biocompatibility | 60-65% | Protein Compound | 93% | Drug Transaction | Liver (direct glucuronidation and CYP1A2 mediated oxidation) | Biological Reaction | 33 hours, 51.8 hours (elderly) | Emission | Urine (57%; 7% as unchanged drug), faeces (30%)</li></ul></td></tr><tr><th>Prescription Requirements</th><td><ul><li>Authorization Information | EMA | NIHB | Pregnant Safety | C | (Austria) | C | (U.S.) | Legal Status | Prescription Requirement (S4) | (Austria) |  | -only | (Canada) | POM | (United Kingdom) |  | -only | (U.S.) | Dosage Method | By mouth, intramuscular injection</li></ul></td></tr></table>